Tuesday, November 27, 2018

These 3 Indian pharma firms to benefit from warning letter to Mylan#39;s US facility

These 3 Indian pharma firms to benefit from warning letter to Mylan#39;s US facility The slowdown in production at Morgantown site could provide a window of opportunity to Mylan#39;s peers

from Moneycontrol Business News https://ift.tt/2QkBUlO

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...